Single-Dose Azithromycin versus Penicillin G Benzathine for the Treatment of Early Syphilis | Zendy

Gabriele Riedner | Zendy; Mary Rusizoka | Zendy; Jim Todd | Zendy; Leonard Maboko | Zendy; Michael Höelscher | Zendy; Donan Mmbando | Zendy; Eleuter Samky | Zendy; Eligius Lyamuya | Zendy; David Mabey | Zendy; Heiner Grosskurth | Zendy; Richard Hayes | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Single-Dose Azithromycin versus Penicillin G Benzathine for the Treatment of Early Syphilis

Author(s) -

Gabriele Riedner,

Mary Rusizoka,

Jim Todd,

Leonard Maboko,

Michael Höelscher,

Donan Mmbando,

Eleuter Samky,

Eligius Lyamuya,

David Mabey,

Heiner Grosskurth,

Richard Hayes

Publication year - 2005

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa044284

Subject(s) - medicine , azithromycin , rapid plasma reagin , confidence interval , syphilis , penicillin , primary syphilis , surgery , antibiotics , immunology , human immunodeficiency virus (hiv) , treponema , microbiology and biotechnology , biology

Pilot studies suggest that a single, 2-g oral dose of azithromycin may be an alternative to a 2.4-MU intramuscular dose of penicillin G benzathine in the prevention and treatment of syphilis. We evaluated the efficacy of treatment with azithromycin in a developing country.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research